Search
BridgeBio Oncology Therapeutics Ord Shs
BBOTAdd to Watchlist
3.990USD
-0.170-4.09%
Close 09-24 16:00（ET）
319.64MMarket Cap
19.79P/E TTM
About Company
BridgeBio Oncology Therapeutics Ord Shs Profile
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of BridgeBio Oncology Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
,
,
--
--
Mr. Pedro J. Beltran, Ph.D.
Mr. Pedro J. Beltran, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Ben (Ben) Yong, M.D.
Mr. Ben (Ben) Yong, M.D.
Chief Medical and Development Officer
Chief Medical and Development Officer
--
--
Ms. Angela Peters
Ms. Angela Peters
Senior Vice President - People
Senior Vice President - People
--
--
Mr. Wang Bin, Ph.D.
Mr. Wang Bin, Ph.D.
Senior Vice President - Drug Discovery
Senior Vice President - Drug Discovery
--
--
Mr. Daniel Watson, Ph.D.
Mr. Daniel Watson, Ph.D.
Senior Vice President - Chemistry, Manufacturing, and Controls
Senior Vice President - Chemistry, Manufacturing, and Controls
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Idan Elmelech
Mr. Idan Elmelech
Chief Operating Officer, Principal Financial Officer
Chief Operating Officer, Principal Financial Officer
14.49K
-2.37%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
Mr. Marc Cobo
Mr. Marc Cobo
Vice President - Finance, Controller, Principal Accounting Officer
Vice President - Finance, Controller, Principal Accounting Officer
14.14K
+62.48%
,
,
--
--
Mr. Pedro J. Beltran, Ph.D.
Mr. Pedro J. Beltran, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
FAQs
Who are the top five shareholders of BridgeBio Oncology Therapeutics Ord Shs?
The top five shareholders of BridgeBio Oncology Therapeutics Ord Shs are: Mr. Idan Elmelech